(Q48394858)

11 February 2018

title

Neuroimaging to assess safety and efficacy of AD therapies. (English)

1 reference

11 February 2018

0 references

Derek Hill

1

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 January 2010

1 reference

11 February 2018

Expert Opinion on Investigational Drugs

published in

1 reference

11 February 2018

volume

19

1 reference

11 February 2018

issue

1

1 reference

11 February 2018

page(s)

23-26

1 reference

11 February 2018

The pilot European Alzheimer's Disease Neuroimaging Initiative of the European Alzheimer's Disease Consortium

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381320

The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381320

Visualisation and quantification of rates of atrophy in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381320

Brain atrophy progression measured from registered serial MRI: validation and application to Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381320

Accurate, robust, and automated longitudinal and cross-sectional brain change analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381320

MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381320

Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381320

Measuring the thickness of the human cerebral cortex from magnetic resonance images

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381320

Cerebral atrophy measurements using Jacobian integration: comparison with the boundary shift integral.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381320

Deformation tensor morphometry of semantic dementia with quantitative validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381320

Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381320

FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381320

Imaging the Abeta-related neurotoxicity of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381320

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381320

11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381320

Impact of amyloid imaging on drug development in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381320

Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381320

Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381320

The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381320

10.1517/13543780903381320

21 January 2018

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

19947893

1 reference

11 February 2018